Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"
Related Research units
Bibliographical data
| Original language | English |
|---|---|
| ISSN | 0960-9776 |
| DOIs | |
| Publication status | Published - 02.2021 |
Comment Deanary
Correction
| PubMed | 33413981 |
|---|
